Cargando…
Recent Advances in Mesoporous Silica Nanoparticle-Mediated Drug Delivery for Breast Cancer Treatment
Breast cancer (BC) currently occupies the second rank in cancer-related global female deaths. Although consistent awareness and improved diagnosis have reduced mortality in recent years, late diagnosis and resistant response still limit the therapeutic efficacy of chemotherapeutic drugs (CDs), leadi...
Autores principales: | Rani, Ruma, Malik, Parth, Dhania, Sunena, Mukherjee, Tapan Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860911/ https://www.ncbi.nlm.nih.gov/pubmed/36678856 http://dx.doi.org/10.3390/pharmaceutics15010227 |
Ejemplares similares
-
Mesoporous silica nanoparticles for drug and gene delivery
por: Zhou, Yixian, et al.
Publicado: (2018) -
Silica-based mesoporous nanoparticles for controlled drug delivery
por: Kwon, Sooyeon, et al.
Publicado: (2013) -
Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights
por: Vallet-Regí, María, et al.
Publicado: (2017) -
Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer
por: Watermann, Anna, et al.
Publicado: (2017) -
Understanding the feasibility of chemotherapeutic and immunotherapeutic targets against non-small cell lung cancers: an update of resistant responses and recent combinatorial therapies
por: Malik, Parth, et al.
Publicado: (2023)